Reneo Pharmaceuticals, Inc.
NASDAQ:RPHM
18.2 (USD) • At close October 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -77.388 | -51.955 | -39.77 | -19.465 | -12.436 |
| Depreciation & Amortization
| 0.525 | 0.088 | 0.05 | 0.037 | 0.034 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | -2.73 |
| Stock Based Compensation
| 0.005 | 0.004 | 0.004 | 0 | 0 |
| Change In Working Capital
| 12.218 | 0.959 | -2.8 | 0.514 | 1.561 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 11.118 | 0.518 | 1.78 | 1.486 | 1.034 |
| Other Working Capital
| 12.218 | 0.441 | -4.58 | -0.972 | 0.527 |
| Other Non Cash Items
| 2.013 | -0.774 | 0.646 | -0.015 | 0.673 |
| Operating Cash Flow
| -63.682 | -47.362 | -37.983 | -18.536 | -12.51 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.221 | -0.346 | -0.198 | -0.024 | -0.007 |
| Acquisitions Net
| 0 | 0.057 | 0.023 | 0 | 0.007 |
| Purchases Of Investments
| -231.257 | -101.596 | -31.406 | 0 | -19.834 |
| Sales Maturities Of Investments
| 242 | 44.1 | 8.228 | 7.4 | 12.6 |
| Other Investing Activites
| 0.011 | -0.057 | -0.023 | 0.007 | -0.007 |
| Investing Cash Flow
| 10.522 | -57.842 | -23.376 | 7.376 | -7.241 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 64.538 | 0.193 | 84.612 | 47.272 | 24.986 |
| Common Stock Repurchased
| -4.403 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.73 | 0.278 | 47.794 | 47.272 | 24.986 |
| Financing Cash Flow
| 60.865 | 0.471 | 132.406 | 47.272 | 24.986 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 7.705 | -104.733 | 71.047 | 36.112 | 5.235 |
| Cash At End Of Period
| 27.632 | 19.927 | 124.66 | 53.613 | 17.501 |